These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 10083531)

  • 1. HLA-G mediates protection from natural killer cytolysis: implications in immune tolerance.
    Carosella ED; Khalil-Daher I; Dausset J; Rouas-Freiss N
    Transplant Proc; 1999; 31(1-2):1192-3. PubMed ID: 10083531
    [No Abstract]   [Full Text] [Related]  

  • 2. The regulation of natural killer-mediated swine endothelial cell lysis by HLA-G (G1 and G3).
    Matsunami K; Miyagawa S; Nakai R; Yamada M; Shirakura R
    Transplant Proc; 2000 Nov; 32(7):2087-8. PubMed ID: 11120079
    [No Abstract]   [Full Text] [Related]  

  • 3. Protection against natural killer-mediated swine endothelial cell lysis by HLA-G and HLA-E.
    Matsunami K; Miyagawa S; Nakai R; Yamada M; Shirakura R
    Transplant Proc; 2000 Aug; 32(5):939-40. PubMed ID: 10936284
    [No Abstract]   [Full Text] [Related]  

  • 4. HLA-G expression protects porcine endothelial cells from xenogeneic cytotoxicity mediated by human natural killer cells.
    Sasaki H; Xu XC; Smith D; Shenoy S; Lowell J; Howard T; Mohanakumar T
    Transplant Proc; 1999; 31(1-2):953-4. PubMed ID: 10083422
    [No Abstract]   [Full Text] [Related]  

  • 5. The alpha1 domain of HLA-G1 and HLA-G2 inhibits cytotoxicity induced by natural killer cells: is HLA-G the public ligand for natural killer cell inhibitory receptors?
    Rouas-Freiss N; Marchal RE; Kirszenbaum M; Dausset J; Carosella ED
    Proc Natl Acad Sci U S A; 1997 May; 94(10):5249-54. PubMed ID: 9144223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A soluble HLA-G protein that inhibits natural killer cell-mediated cytotoxicity.
    Marchal-Bras-Goncalves R; Rouas-Freiss N; Connan F; Choppin J; Dausset J; Carosella ED; Kirszenbaum M; Guillet J
    Transplant Proc; 2001 May; 33(3):2355-9. PubMed ID: 11377558
    [No Abstract]   [Full Text] [Related]  

  • 7. Role of HLA-G versus HLA-E on NK function: HLA-G is able to inhibit NK cytolysis by itself.
    Khalil-Daher I; Riteau B; Menier C; Sedlik C; Paul P; Dausset J; Carosella ED; Rouas-Freiss N
    J Reprod Immunol; 1999 Jul; 43(2):175-82. PubMed ID: 10479053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Fetomaternal tolerance: role of HLA-G molecule in the protection of the fetus against maternal natural killer activity].
    Rouas-Freiss N; Kirszenbaum M; Dausset J; Carosella ED
    C R Acad Sci III; 1997 May; 320(5):385-92. PubMed ID: 9239324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of HLA-G in maternal-fetal immune tolerance.
    Rouas-Freiss N; Khalil-Daher I; Marchal-Bras Goncalves R; Menier C; Dausset J; Carosella ED
    Transplant Proc; 1999; 31(1-2):724-5. PubMed ID: 10083309
    [No Abstract]   [Full Text] [Related]  

  • 10. A human histocompatibility leukocyte antigen (HLA)-G-specific receptor expressed on all natural killer cells.
    Rajagopalan S; Long EO
    J Exp Med; 1999 Apr; 189(7):1093-100. PubMed ID: 10190900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HLA-G promotes immune tolerance.
    Rouas-Freiss N; Paul P; Dausset J; Carosella ED
    J Biol Regul Homeost Agents; 2000; 14(2):93-8. PubMed ID: 10841284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HLA-G truncated isoforms can substitute for HLA-G1 in fetal survival.
    Menier C; Riteau B; Dausset J; Carosella ED; Rouas-Freiss N
    Hum Immunol; 2000 Nov; 61(11):1118-25. PubMed ID: 11137216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Direct evidence to support the role of HLA-G in protecting the fetus from maternal uterine natural killer cytolysis.
    Rouas-Freiss N; Gonçalves RM; Menier C; Dausset J; Carosella ED
    Proc Natl Acad Sci U S A; 1997 Oct; 94(21):11520-5. PubMed ID: 9326642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HLA-G1-transfected K562 cells do not inhibit NK-cell-mediated lysis in europium release cytotoxicity assay.
    Sapak M; Buc M
    Bratisl Lek Listy; 2003; 104(10):300-4. PubMed ID: 15055728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A study of HLA-G1 protection of porcine endothelial cells against human NK cell cytotoxicity.
    Wang SS; Han JY; Wu XW; Cao RH; Qi HG; Xia ZX; Chen D; Gong FL; Chen S
    Transplant Proc; 2004 Oct; 36(8):2473-4. PubMed ID: 15561285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HLA-G2, -G3, and -G4 isoforms expressed as nonmature cell surface glycoproteins inhibit NK and antigen-specific CTL cytolysis.
    Riteau B; Rouas-Freiss N; Menier C; Paul P; Dausset J; Carosella ED
    J Immunol; 2001 Apr; 166(8):5018-26. PubMed ID: 11290782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid production of human KIR2DL4 extracellular domain and verification of its interaction with HLA-G.
    Yu YR; Tian XH; Wang Y; Feng MF
    Biochemistry (Mosc); 2006; 71 Suppl 1():S60-4, 4-5. PubMed ID: 16487070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aberrant human leucocyte antigen-G expression and its clinical relevance in hepatocellular carcinoma.
    Lin A; Chen HX; Zhu CC; Zhang X; Xu HH; Zhang JG; Wang Q; Zhou WJ; Yan WH
    J Cell Mol Med; 2010 Aug; 14(8):2162-71. PubMed ID: 19799650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Porcine aortic endothelial cells transfected with HLA-G are partially protected from xenogeneic human NK cytotoxicity.
    Forte P; Matter-Reissmann UB; Strasser M; Schneider MK; Seebach JD
    Hum Immunol; 2000 Nov; 61(11):1066-73. PubMed ID: 11137209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HLA-G expression in human melanoma cells: protection from NK cytolysis.
    Adrián Cabestré F; Moreau P; Riteau B; Ibrahim EC; Le Danff C; Dausset J; Rouas-Freiss N; Carosella ED; Paul P
    J Reprod Immunol; 1999 Jul; 43(2):183-93. PubMed ID: 10479054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.